« Back to the previous page

European pharmaceutical consultant company wanted

Company to buy

• Size: small business
• Revenue: 1-2M EUR
• Employees count: 5-10
• Preferred location: European community
• Reason for acquisition: The management of the buyer wants to strengthen its position in the market, and therefore priority is given to cross-selling existing products to existing clients, and international expansion, which is why CFIE is in touch with this buyer
• #CFIE PHB011

Overview of this buyer for European consultancy company

The management of a European pharma consultancy company has decided to grow internationally via M&A. The buyer has a long history, and good clients base, from which the potential target could benefit. The management is looking for both new and dynamic companies and well-established consultants firms with up to 10 individual consultants.

Profile (strategy) of this buyer for European consultancy company

The buyer of the consultancy company is a well-established pharmaceutical consultant company established more than 20 years ago. The company is helping both domestic and international companies that need consultations in the pharma industry. The clients are mainly from

• Pharmaceutical Companies
  
• Biotech Companies
  
• Medical Device Manufacturers Diagnostic Test Machines developers
  

The main activity of the company is helping its clients with regulatory compliance requirements. This includes:

• regulatory affairs compliance
  
• market access
  
• validation
  
• clinical research
  
• quality systems
  
• e-CTD generation
  
• pharmacovigilance consulting etc.
  

The company is currently reaching revenue of more than 2 million EUR per year. As the management is placing the accent on external growth, international expansion is on the table.

Activities and products of the target company

The company is looking to acquire a small consultant for the European pharmaceutical industry based in any country in Europe, preferably the EU. The ideal target should be involved in one of the following:

• drug regulatory affairs
  
• pharmacovigilance
  
• the provision of information regarding the rational use of medicinal products
  
• market access
  
• small-scale clinical trials
  

The revenue of the target should be ideally between 1 and 1.5 million with positive EBITDA around ±150k EUR. The company should have more than 5 consultants.

Highlights of this buyer for European consultancy company

• The buyer is a consultancy firm with a good portfolio of clients and experience in the field of pharma outsourcing
• The buyer has more than 50 clients from large pharma companies and conglomerates
• The target should be a consultancy firm with experienced consultants and stable team

Information about this buyer for pharma consultancy company in Europe

Feel free to contact us for more information regarding this pharmaceutical consultancy company buyer. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale. If you have other intentions in the pharma sector, reach out to us – we know the pharmaceutical M&A market and we are ready to help you.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.